Systemic Chemotherapy Plus HAI(FUDR）vs Systemic Chemotherapy Alone For CRCLM
Status:
Recruiting
Trial end date:
2024-12-31
Target enrollment:
Participant gender:
Summary
The aim of the trial is to optimize the overall survival of patients with resectable
colorectal liver metastasis who have undergone liver metastasis resection. The patients will
be treated with systemic chemotherapy plus hepatic arterial infusion With floxuridine, or
with systemic chemotherapy only